Related Experiment Videos
Modified constraint-induced therapy and botulinum toxin A: a promising combination
Stephen J Page1, Elie Elovic, Peter Levine
1Kessler Medical Rehabilitation Research and Education Corportation, West Orang, New Jersey, USA.
American Journal of Physical Medicine & Rehabilitation
|January 3, 2003
Summary
Combining modified constraint-induced therapy and botulinum toxin A injections may enhance motor function recovery after stroke. This approach addresses persistent upper limb deficits, improving hand function and overall recovery in stroke survivors.
Area of Science:
- Neurorehabilitation
- Stroke Recovery
- Movement Disorders
Background:
- Modified constraint-induced therapy (mCIT) and chemodeneration with botulinum toxin A are effective for stroke-induced motor impairments.
- The combined efficacy of mCIT and botulinum toxin A has not been previously investigated.
Observation:
- A 44-year-old male with a right middle cerebral artery infarct presented with residual upper limb dysfunction.
- Following mCIT, the patient showed improved upper limb use but persistent finger extension difficulty due to forearm flexor spasticity.
Findings:
- Selective chemodeneration of forearm flexor muscles with botulinum toxin A significantly improved finger extension.
- The patient reported enhanced self-perceived hand function and demonstrated better scores on objective measures.
Implications:
- Combining mCIT with botulinum toxin A may offer a synergistic approach to stroke motor rehabilitation.
- This case suggests a potential strategy for optimizing functional recovery in patients with persistent post-stroke spasticity and motor deficits.